BMS-986020
BMS-986020 Basic information
- Product Name:
- BMS-986020
- Synonyms:
-
- BMS-986020
- CS-2492
- (R)-1-(4'-(3-methyl-4-(((1-phenylethoxy)carbonyl)amino)isoxazol-5-yl)-[1,1'-biphenyl]-4-yl)cyclopropane-1-carboxylic acid
- BMS-986020;BMS 986020;BMS986020
- 1-{4'-[3-methyl-4-((R)-1-phenyl-ethoxycarbonylamino)-isoxazol-5-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid
- AM152
- Cyclopropanecarboxylic acid, 1-[4'-[3-methyl-4-[[[(1R)-1-phenylethoxy]carbonyl]amino]-5-isoxazolyl][1,1'-biphenyl]-4-yl]-
- inhibit,idiopathic,AM-152,LPL Receptor,Lysophospholipid Receptor,AM 152,IPF,BMS-986020,fibrosis,pulmonary,BMS 986020,autoradiography,Inhibitor,ARG
- CAS:
- 1257213-50-5
- MF:
- C29H26N2O5
- MW:
- 482.53
- Mol File:
- 1257213-50-5.mol
More
Less
BMS-986020 Chemical Properties
- Melting point:
- 174-180°C
- Boiling point:
- 664.8±55.0 °C(Predicted)
- Density
- 1.309±0.06 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- solubility
- DMSO (Slightly), Methanol (Slightly, Sonicated)
- form
- Solid
- pka
- 4.19±0.20(Predicted)
- color
- White to Off-White
More
Less
BMS-986020 Usage And Synthesis
Description
BMS 986020 is a potent G protein-coupled lysophosphatidic acid receptor 1 (LPA1) antagonist with an IC50 value less than 300 nM for human LPA1 expressing CHO cells. Formulations containing BMS 986020 are being investigated in clinical trials for efficacy in idiopathic pulmonary fibrosis.
Uses
BMS-?986020 is an LPA-1 antagonist which may be used in the inhibition and treatment of bleomycin-induced pulminary fibrosis.
BMS-986020Supplier
Kaixin Chemical (Hong Kong) Limited Gold
- Tel
- 010-88886666-01 13112345678
- loyson@tcypharm.com
Shanghai Boyle Chemical Co., Ltd.
- Tel
- sales@boylechem.com
Haoyuan Chemexpress Co., Ltd.
- Tel
- 021-58950125
- info@chemexpress.com
SHANGHAI SINOCHEMTECH CO.,LTD.
- Tel
- 86-21-37788339
Suzhou Sino Rare Chemical Co., Ltd.
- Tel
- 0512-62857507
- sales@sinorarechem.com